AMTI — Applied Molecular Transport. Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $11.01m
- -$7.10m
Annual cashflow statement for Applied Molecular Transport., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -29.9 | -28 | -66.6 | -100 | -126 |
| Depreciation | |||||
| Non-Cash Items | 0.34 | 0.468 | 2.94 | 21.1 | 31.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.45 | -0.098 | 2.89 | -6.64 | -2.24 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -27.4 | -27 | -58.9 | -82.6 | -93.9 |
| Capital Expenditures | -0.545 | -2.15 | -5.32 | -1.86 | -4.15 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -20 | -104 | 124 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.545 | -22.1 | -109 | 122 | -4.15 |
| Financing Cash Flow Items | 0 | -0.132 | -3.95 | -0.097 | -0.565 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 30.9 | 41.6 | 161 | 115 | -0.733 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.93 | -7.45 | -6.88 | 155 | -98.8 |